Bivalent rLP2086
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Bivalent rLP2086, covering 2015-05-25 to 2018-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers. [Phase 2]